- TRADE NAME: Bredinin (Asahi Kasei Pharma)
- INDICATIONS: Rheumatoid arthritis, systemic lupus erythematosus, prevention of rejection in renal transplantation, lupus nephritis, nephrotic syndrome
- CLASS: Immunosuppressant
- HALF-LIFE: 6 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 01/07/2024
